Welcome To Website IAS

Hot news
Achievement

Independence Award

- First Rank - Second Rank - Third Rank

Labour Award

- First Rank - Second Rank -Third Rank

National Award

 - Study on food stuff for animal(2005)

 - Study on rice breeding for export and domestic consumption(2005)

VIFOTEC Award

- Hybrid Maize by Single Cross V2002 (2003)

- Tomato Grafting to Manage Ralstonia Disease(2005)

- Cassava variety KM140(2010)

Centres
Website links
Vietnamese calendar
Library
Visitors summary
 Curently online :  17
 Total visitors :  7658346

FDA Approves CRISPR-based Therapeutic for Trial
Saturday, 2022/09/03 | 07:13:32

Cure Rare Disease, a Boston-based nonprofit organization developing genetic medicines, has received approval from the Food and Drug Administration (FDA) to administer its CRISPR-based therapeutic that halts the progression of Duchenne muscular dystrophy.

 

Duchenne muscular dystrophy is a rare genetic disease caused by a mutation in the gene responsible for dystrophin production. It can affect all muscle types and leads to loss of mobility and eventually to respiratory and cardiac failure. The disease impacts 1 in 3,500 males and is extremely rare in females.

 

The drug, CRD-TMH-001, treats muscle promoter and exon 1 mutations on the dystrophin gene. With the FDA approval, dosing of the drug will take place at the University of Massachusetts Medical School very soon.

 

The therapeutic has been developed for one-time administration. It will be administered intravenously, and the patient will be under observation in the hospital for several days to ensure that there are no uncontrolled adverse reactions. As per FDA guidelines, the patient's progress will be tracked for 15 years.

 

Read more from Cure Rare Disease.

Back      Print      View: 165

[ Other News ]___________________________________________________
  • Egypt Holds Workshop on New Biotech Applications
  • UN Agencies Urge Transformation of Food Systems
  • Taiwan strongly supports management of brown planthopper—a major threat to rice production
  • IRRI Director General enjoins ASEAN states to invest in science for global food security
  • Rabies: Educate, vaccinate and eliminate
  • “As a wife I will help, manage, and love”: The value of qualitative research in understanding land tenure and gender in Ghana
  • CIP Director General Wells Reflects on CIP’s 45th Anniversary
  • Setting the record straight on oil palm and peat in SE Asia
  • Why insect pests love monocultures, and how plant diversity could change that
  • Researchers Modify Yeast to Show How Plants Respond to Auxin
  • GM Maize MIR162 Harvested in Large Scale Field Trial in Vinh Phuc, Vietnam
  • Conference Tackles Legal Obligations and Compensation on Biosafety Regulations in Vietnam
  • Iloilo Stakeholders Informed about New Biosafety Regulations in PH
  • Global wheat and rice harvests poised to set new record
  • GM Maize Harvested in Vietnam Field Trial Sites
  • New label for mountain products puts premium on biological and cultural diversity
  • The Nobel Prize in Physiology or Medicine 2016
  • Shalabh Dixit: The link between rice genes and rice farmers
  • People need affordable food, but prices must provide decent livelihoods for small-scale family farmers
  • GM Seeds Market Growth to Increase through 2020 Due to Rise in Biofuels Use

 

Designed & Powered by WEBSO CO.,LTD